Page 368 - v11i4
P. 368

International Journal of Bioprinting                                Sr-doped printed scaffolds for bone repair




































            Figure 6. BMSCs viability assay on scaffolds. (A) Live-dead cell staining after 3 days of co-culturing BMSCs within P, SBP, and PSBP scaffolds. (B)
            Cell proliferation within the P, SBP, and PSBP scaffolds on days 1, 3, and 7 (n = 3; *p < 0.05, **p < 0.01). Scale bar: 500 μm (A). Abbreviations: BMSCs,
            bone marrow mesenchymal stem cells; OD, optical density; P, polycaprolactone (PCL); PSBP, Polydopamine (PDA)/strontium (Sr)-doped bioactive glass
            (SrBG)/polycaprolactone (PCL); SBP, strontium (Sr)-doped bioactive glass (SrBG)/polycaprolactone (PCL).


            than that in the P scaffold (p < 0.01); after 7 days of    and SBP scaffolds, suggesting a positive effect on bone
            co-culture, cell proliferation in the PSBP and SBP scaffolds   differentiation. On day 14,  ALP expression in the PSBP
            was significantly higher compared to the P scaffold    scaffold was 7.1 and 2.4 times higher than that in the SBP
            (p < 0.05).                                        and P scaffolds, respectively;  RUNX2 expression in the
                                                               PSBP scaffold was 10.3 and 3.2 times higher than that in
            3.2.2. Bone-enhancing properties of P, SBP, and    the SBP and P scaffolds, respectively; and COL1 expression
            PSBP scaffolds                                     in the PSBP scaffold was 8.5 and 7.1 times higher than that
            To assess the early osteogenic activity of the scaffolds, the P,   in the SBP and P scaffolds, respectively (Figure 7B). These
            SBP, and PSBP scaffolds were co-cultured with BMSCs for   observations indicate that the  PSBP scaffold  had better
            7 days and then subjected to ALP staining. The P scaffold   immunomodulatory ability to promote the osteogenic
            exhibited weaker  and  lighter  ALP staining, indicating a   differentiation of BMSCs compared to the P and SBP
            limited effect on promoting osteoblast differentiation. In   scaffolds (p < 0.05).
            contrast, the SBP scaffold, which included SrBG, displayed
            markedly increased and intensified intracellular ALP   3.2.3. Immunomodulatory capacity of P, SBP, and
            staining. The PSBP scaffold, incorporating both SrBG and   PSBP scaffolds
            PDA, demonstrated the most pronounced ALP staining,   To assess the immunomodulatory properties of the
            suggesting a synergistic enhancement of osteogenic   scaffolds, the expression of MP polarization-related genes
            differentiation (Figure 7A1). The ALP activity in the PSBP   was detected by co-culturing RAW264.7 cells with the P,
            scaffold was significantly higher than that in the P and SBP   SBP, and PSBP scaffolds for 1 and 3 days. The expression
            scaffolds (p ≤ 0.001) (Figure 7A2). To assess the effects of   of M2-MP polarization genes (CD206 and  ARG) was
            the scaffolds on the osteogenic differentiation of BMSCs,   significantly upregulated in the PSBP scaffold compared to
            the expression of osteogenesis-related genes (COL1, ALP,   the P and SBP scaffolds (Figure 8A3 and A4). In contrast,
            and  RUNX2)  was  assessed  after  co-culturing  BMSCs   the PSBP scaffold significantly inhibited the expression
            with the scaffolds for 7 and 14 days in MP medium. The   of  M1–MP  polarization  genes  (TNF-α  and  IL1β)
            expressions of COL1, ALP, and RUNX2 were significantly   (Figure 8A1 and A2). On day 3, ARG gene expression in the
            upregulated in the PSBP scaffold compared to the P   PSBP scaffold was 7.1 and 4.3 times higher than that in the


            Volume 11 Issue 4 (2025)                       360                            doi: 10.36922/IJB025210211
   363   364   365   366   367   368   369   370   371   372   373